Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cortesi

Showing results (111-120 of 181) with videos related to

Pageof 19
Sort By:
Breast (Edinburgh, Scotland)|May 27, 2025
Advancing breast cancer therapy in the era of molecular diagnosticsMaria Grazia Carnevale, Riccardo Ray Colciago, Maria Carmen De Santis, et al.
Journal of Personalized Medicine|July 2, 2021
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast StudyAngela Toss, Amelia Spinella, Chrystel Isca, et al.
Cancers|September 28, 2021
Transcriptome of Male Breast Cancer Matched with Germline Profiling Reveals Novel Molecular Subtypes with Possible Clinical RelevanceVeronica Zelli, Valentina Silvestri, Virginia Valentini, et al.
Frontiers in Oncology|December 19, 2022
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapyAngela Toss, Marta Venturelli, Monica Civallero, et al.
Breast Cancer Research and Treatment|August 28, 2021
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9)Rosalba Torrisi, Raffaella Palumbo, Rita De Sanctis, et al.
European Journal of Human Genetics : EJHG|September 2, 2004
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutationsFabio Marroni, Paolo Aretini, Emma D'Andrea, et al.
Journal of the National Cancer Institute|August 29, 2025
Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase III trial in non-invasive breast cancerAlessio Carbone, Martino Oliva, Matteo Puntoni, et al.
Communications Medicine|March 8, 2025
Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndromeGiovanna Sighinolfi, Giovanni Grandi, Elena Barbieri, et al.
Cancers|August 11, 2019
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)Maria Vittoria Dieci, Lucia Del Mastro, Michela Cinquini, et al.
Journal of Personalized Medicine|December 23, 2022
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast StudyChrystel Isca, Amelia Spinella, Angela Toss, et al.
Pageof 19

Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
Breast (Edinburgh, Scotland)|May 27, 2025
Advancing breast cancer therapy in the era of molecular diagnosticsMaria Grazia Carnevale, Riccardo Ray Colciago, Maria Carmen De Santis, et al.
Journal of Personalized Medicine|July 2, 2021
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast StudyAngela Toss, Amelia Spinella, Chrystel Isca, et al.
Cancers|September 28, 2021
Transcriptome of Male Breast Cancer Matched with Germline Profiling Reveals Novel Molecular Subtypes with Possible Clinical RelevanceVeronica Zelli, Valentina Silvestri, Virginia Valentini, et al.
Frontiers in Oncology|December 19, 2022
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapyAngela Toss, Marta Venturelli, Monica Civallero, et al.
Breast Cancer Research and Treatment|August 28, 2021
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9)Rosalba Torrisi, Raffaella Palumbo, Rita De Sanctis, et al.
European Journal of Human Genetics : EJHG|September 2, 2004
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutationsFabio Marroni, Paolo Aretini, Emma D'Andrea, et al.
Journal of the National Cancer Institute|August 29, 2025
Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase III trial in non-invasive breast cancerAlessio Carbone, Martino Oliva, Matteo Puntoni, et al.
Communications Medicine|March 8, 2025
Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndromeGiovanna Sighinolfi, Giovanni Grandi, Elena Barbieri, et al.
Cancers|August 11, 2019
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)Maria Vittoria Dieci, Lucia Del Mastro, Michela Cinquini, et al.
Journal of Personalized Medicine|December 23, 2022
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast StudyChrystel Isca, Amelia Spinella, Angela Toss, et al.
Pageof 19